CCNB1IP1 Antikörper (AA 151-250) (FITC)
Kurzübersicht für CCNB1IP1 Antikörper (AA 151-250) (FITC) (ABIN888540)
Target
Alle CCNB1IP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 151-250
-
Homologie
- Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human ccnb1ip1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CCNB1IP1 (Cyclin B1 Interacting Protein 1 (CCNB1IP1))
-
Andere Bezeichnung
- ccnb1ip1
-
Hintergrund
-
Synonyms: C14orf18, CCNB1IP1, Chromosome 14 open reading frame 18, CIP1_HUMAN, Cyclin B1 interacting protein 1, Cyclin-B1-interacting protein 1, E3 ubiquitin-protein ligase CCNB1IP1, Enhancer of invasion 10, HEI10, Human enhancer of invasion 10.
Background: E3 ubiquitin-protein ligase. Modulates cyclin B levels and participates in the regulation of cell cycle progression through the G2 phase. Overexpression causes delayed entry into mitosis.Tissue specificity: Highly expressed in heart. Detected at intermediate levels in liver and kidney, and at low levels in placenta, brain and lung.
-
Gen-ID
- 57820
Target
-